SIMBEC RESEARCH LIMITED – MIA(IMP) 4757
| Authorisation Number | UK MIA(IMP) 4757 |
| Category | MIA(IMP) |
| Holder | SIMBEC RESEARCH LIMITED |
| Registered Address | SIMBEC RESEARCH LIMITED, SIMBEC HOUSE, MERTHYR TYDFIL INDUSTRIAL PARK, MERTHYR TYDFIL, CF48 4DR, UNITED KINGDOM |
| Authorisation Date | Jul 07, 2026 |
| Legal Basis | InvestigationalPart 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 [SI 2004/1031] |
| Sites | 1 |
| Manufacturing Operations | 1.1 1.1.1 1.1.1.1 1.1.1.4 1.1.1.5 1.1.1.6 1.1.3 1.2 1.2.1 1.2.1.1 1.2.1.15 1.2.1.2 1.2.1.5 1.2.1.6 1.2.1.9 1.2.2 1.3 1.3.1 1.3.1.8 1.5 1.5.1 1.5.1.1 1.5.1.12 1.5.1.13 1.5.1.14 1.5.1.15 1.5.1.2 1.5.1.3 1.5.1.4 1.5.1.5 1.5.1.6 1.5.2 |
| Importation Operations | 2.2 2.2.1 2.2.1.1 2.2.1.2 2.2.2 2.2.3 2.2.3.5 2.3 2.3.1 2.3.2 2.3.4 |
| MHRA Link | View on MHRA Website |
Sites (2)
SIMBEC RESEARCH LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.1 — Large volume liquids
1.1.1.4 — Small volume liquids
1.1.1.5 — Solids and implants
1.1.1.6 — Other aseptically prepared products
1.1.3 — Batch certification
1.2 — Non-sterile investigational medicinal products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.2 — Capsules, soft shell
1.2.1.5 — Liquids for external use
1.2.1.6 — Liquids for internal use
1.2.1.9 — Pressurised preparations
1.2.1.15 — Other non-sterile medicinal products
1.2.2 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.8 — Other biological medicinal products
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.2 — Capsules, soft shell
1.5.1.3 — Chewing gums
1.5.1.4 — Impregnated matrices
1.5.1.5 — Liquids for external use
1.5.1.6 — Liquids for internal use
1.5.1.12 — Suppositories
1.5.1.13 — Tablets
1.5.1.14 — Transdermal patches
1.5.1.15 — Other non-sterile medicinal products
1.5.2 — Secondary packaging
Importation
2.2 — Batch certification of imported medicinal products
2.2.1 — Sterile Products
2.2.1.1 — Aseptically prepared
2.2.1.2 — Terminally sterilised
2.2.2 — Non-sterile products
2.2.3 — Biological medicinal products
2.2.3.5 — Biotechnology products
2.3 — Other Importation Activities
2.3.1 — Site of Physical Importation
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Other
SIMBEC RESEARCH LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.1 — Sterile Investigational Medicinal Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.1 — Large volume liquids
1.1.1.4 — Small volume liquids
1.1.1.5 — Solids and implants
1.1.1.6 — Other aseptically prepared products
1.1.3 — Batch certification
1.2 — Non-sterile investigational medicinal products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.2 — Capsules, soft shell
1.2.1.5 — Liquids for external use
1.2.1.6 — Liquids for internal use
1.2.1.9 — Pressurised preparations
1.2.1.15 — Other non-sterile medicinal products
1.2.2 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.8 — Other biological medicinal products
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.2 — Capsules, soft shell
1.5.1.3 — Chewing gums
1.5.1.4 — Impregnated matrices
1.5.1.5 — Liquids for external use
1.5.1.6 — Liquids for internal use
1.5.1.12 — Suppositories
1.5.1.13 — Tablets
1.5.1.14 — Transdermal patches
1.5.1.15 — Other non-sterile medicinal products
1.5.2 — Secondary packaging
Importation
2.2 — Batch certification of imported medicinal products
2.2.1 — Sterile Products
2.2.1.1 — Aseptically prepared
2.2.1.2 — Terminally sterilised
2.2.2 — Non-sterile products
2.2.3 — Biological medicinal products
2.2.3.5 — Biotechnology products
2.3 — Other Importation Activities
2.3.1 — Site of Physical Importation
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Other
Content Preview
The source document is available on KeyPedia. Sign in to view.